Canada: A landmark population-based study published in The Lancet Child & Adolescent Health has revealed that children and ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

Here's what kidney stones are, what causes them and how you can expect to have them treated if they affect you or someone you ...

Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...

Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable ...

The latest clinical win follows a dual set of phase 3 and phase 2 results back in March. In that data drop, Mineralys reported that lorundrostat reduced systolic blood pressure in a late-stage study ...

Chen also says that air pollution harms blood vessels, including the tiny ones in the kidneys, which can reduce blood flow ...

NEARLY half of patients admitted to hospitals in Malawi and Tanzania have been found to be suffering from multi-morbidity, ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and ...

Kidney cancer, can happen due to various reasons, one of them is Chronic Kidney Disease. CKD can lead to gradual kidney ...